4,0
21 mrt 2017
Anonieme werknemer
Voormalige werknemer
South San Francisco, CA
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Best drug developer in the world. Great minds and thorough strategic assessment of opportunities. Play in oncology and other specialty areas which allow for great ROI.
Minpunten
Gone but not forgotten. Current version of company is slowly evolving to become more like Roche. Loss of Ian is a big deal. Bill is not a suitable replacement.